Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:24 PM
Ignite Modification Date:
2025-12-24 @ 9:24 PM
NCT ID:
NCT04392232
Eligibility Criteria:
• Eligibility Criteria
* Participants will be 16 years or older.
* COVID-19 infection demonstrated via SARS-CoV-2 PCR testing.
* Admitted to the hospital for treatment of Covid 19.
* Patients must have severe/high risk disease as defined by the presence of any one of the following:
Respiratory frequency ≥ 25/minute Oxygen saturation ≤ 93% on room air Partial pressure of arterial oxygen to fraction of inspired oxygen ration \< 300, or pulse oximetric saturation to fraction of inspired oxygen ratio \< 315.
Lung infiltrates \> 50% within 24-48 hours of admission on Chest X-Ray or, Ferritin \> 1000 or absolute lymphocyte count \< 600 or D-Dimer \> 1.00
* ABO Blood Type available.
* Pregnant women will be permitted to participate in this study.
• Exclusion criteria
* Previous history of life threatening or severe adverse reactions to transfusion blood products..
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT04392232
Study Brief:
Protocol Section:
NCT04392232